FI951276A - Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit - Google Patents

Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit Download PDF

Info

Publication number
FI951276A
FI951276A FI951276A FI951276A FI951276A FI 951276 A FI951276 A FI 951276A FI 951276 A FI951276 A FI 951276A FI 951276 A FI951276 A FI 951276A FI 951276 A FI951276 A FI 951276A
Authority
FI
Finland
Prior art keywords
improved properties
antibody conjugates
conjugates
antibody
properties
Prior art date
Application number
FI951276A
Other languages
English (en)
Swedish (sv)
Other versions
FI951276A0 (fi
Inventor
Brendan Murray
Terence O'reilly
Gerd Pluschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI951276A0 publication Critical patent/FI951276A0/fi
Publication of FI951276A publication Critical patent/FI951276A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI951276A 1994-03-21 1995-03-17 Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit FI951276A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810173 1994-03-21

Publications (2)

Publication Number Publication Date
FI951276A0 FI951276A0 (fi) 1995-03-17
FI951276A true FI951276A (fi) 1995-09-22

Family

ID=8218230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951276A FI951276A (fi) 1994-03-21 1995-03-17 Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit

Country Status (11)

Country Link
JP (1) JPH0820545A (fi)
KR (1) KR950031111A (fi)
AU (1) AU1481795A (fi)
CA (1) CA2144936A1 (fi)
FI (1) FI951276A (fi)
HU (1) HUT71776A (fi)
IL (1) IL113022A (fi)
NO (1) NO951061L (fi)
NZ (1) NZ270734A (fi)
RU (1) RU95104325A (fi)
ZA (1) ZA952269B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible

Also Published As

Publication number Publication date
IL113022A0 (en) 1995-06-29
ZA952269B (en) 1995-09-21
CA2144936A1 (en) 1995-09-22
KR950031111A (ko) 1995-12-18
AU1481795A (en) 1995-09-28
JPH0820545A (ja) 1996-01-23
HU9500586D0 (en) 1995-04-28
HUT71776A (en) 1996-01-29
FI951276A0 (fi) 1995-03-17
NZ270734A (en) 1997-05-26
RU95104325A (ru) 1996-12-27
IL113022A (en) 2000-02-29
NO951061D0 (no) 1995-03-20
NO951061L (no) 1995-09-22

Similar Documents

Publication Publication Date Title
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
ID16966A (id) Sediaan antibodi pekat
DE69720320D1 (de) Interferon-Konjugate
ATE394489T1 (de) Streptococcus antigene
DK145493D0 (da) Antistof
DK1421956T3 (da) Polyol-IFN-beta-konjugater
DE69515514T2 (de) Absorbierender artikel mit verbesserten eigenschaften
DE69525651T2 (de) Pulsradar mit suchlaufentfernungsgatter
DE69529288D1 (de) Wasserlösliche polyen-konjugate
IS4696A (is) Flugvél með vængbarðakný
NO972868D0 (no) Oligonukleotid-dendrimer konjugater
DE69512585T2 (de) Faltblenden
DE59507277D1 (de) Falzapparat
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
FI951276A (fi) Parannettuja ominaisuuksia omaavat vasta-ainekonjugaatit
KR950029468U (ko) 때밀이기
KR960011059U (ko) 개선된 스토퍼 조립체
SE9002479D0 (sv) Antibody conjugates
DE69123256D1 (de) Antigen-antikörperkonjugaten
DE29521724U1 (de) Schnellhefter
DE9406082U1 (de) Ordner
SE8902432D0 (sv) Antibody conjugates
KR950023844U (ko) 쎈추로
BR9504175A (pt) Jornal-jogo americano
KR960011925U (ko) 화살

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG